Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

Author： Charehbili Ayoub   Fontein Duveken B. Y.   Kroep Judith R.   Liefers Gerrit-Jan   Nortier Johannes W. R.   van de Velde Cornelis J. H.  

Publisher： MDPI

E-ISSN： 2077-0383|2|4|188-200

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.2, Iss.4, 2013-10, pp. : 188-200

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-05 ,pp. : 246-255

Karger

Access to resources Recommend Favorite

The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 217-222

Karger

Access to resources Recommend Favorite

Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete Response

By  

Chemotherapy, Vol. 59, Iss. 5, 2014-05 ,pp. : 387-394

Karger

Access to resources Recommend Favorite

Tailoring Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Historical Prospective Study

By  

Chemotherapy, Vol. 58, Iss. 2, 2012-02 ,pp. : 95-101

Karger

Access to resources Recommend Favorite

Second-Line Combination Chemotherapy with Vinorelbine and Capecitabine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines and/or Taxanes

By  

Chemotherapy, Vol. 57, Iss. 1, 2011-02 ,pp. : 71-76

Karger

Access to resources Recommend Favorite